Package 59762-1003-1

{"route": ["ORAL"], "spl_id": "d4ab5d7b-b3f2-41d8-bd06-e3a85695264e", "openfda": {"nui": ["N0000175550", "N0000175625", "N0000175624", "N0000175605", "N0000175076"], "unii": ["W36ZG6FT64"], "rxcui": ["349208", "360110", "905158"], "spl_set_id": ["5908cd1a-fc5a-462f-99ed-1d8983e253c9"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["mTOR Inhibitor Immunosuppressant [EPC]", "Kinase Inhibitor [EPC]"], "pharm_class_moa": ["mTOR Inhibitors [MoA]", "Protein Kinase Inhibitors [MoA]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, SUGAR COATED in 1 BOTTLE (59762-1003-1)", "package_ndc": "59762-1003-1", "marketing_start_date": "20141027"}], "brand_name": "Sirolimus", "product_id": "59762-1003_d4ab5d7b-b3f2-41d8-bd06-e3a85695264e", "dosage_form": "TABLET, SUGAR COATED", "pharm_class": ["Decreased Immunologic Activity [PE]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]", "mTOR Inhibitor Immunosuppressant [EPC]", "mTOR Inhibitors [MoA]"], "product_ndc": "59762-1003", "generic_name": "SIROLIMUS", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sirolimus", "active_ingredients": [{"name": "SIROLIMUS", "strength": "2 mg/1"}], "application_number": "NDA021110", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "20141027", "listing_expiration_date": "20261231"}